GUFIC BIOSCIENCES Financial Statement Analysis
|
||
The Revenues of GUFIC BIOSCIENCES have decreased by 0.00% YoY .
The Earnings Per Share (EPS) of GUFIC BIOSCIENCES has decreased by -19.09 % YoY. |
REVENUES |
OPERATING MARGIN |
PROFIT AFTER TAX |
EPS |
ROCE |
GUFIC BIOSCIENCES Last 5 Annual Financial Results
[BOM: 509079|NSE : GUFICBIO]
Consolidated | Mar2025 | Mar2024 |
---|---|---|
Revenues | ₹807 Cr | ₹807 Cr |
Expenses | ₹659 Cr | ₹659 Cr |
Operating Profit (Excl OI) | ₹147 Cr | ₹147 Cr |
Other Income | ₹2.18 Cr | ₹2.18 Cr |
Interest | ₹17 Cr | ₹17 Cr |
Depreciation | ₹17 Cr | ₹17 Cr |
Profit Before Tax | ₹116 Cr | ₹116 Cr |
Profit After Tax | ₹86 Cr | ₹86 Cr |
Consolidated Net Profit | ₹86 Cr | ₹86 Cr |
Earnings Per Share (Rs) | ₹6.95 | ₹8.59 |
PAT Margin (%) | 6.33 | 9.16 |
ROE(%) | 12.29 | 16.17 |
ROCE(%) | 13.48 | 15.59 |
Total Debt/Equity(x) | 0.52 | 0.60 |
Key Financials |
||
Market Cap | : | ₹ 3,503.0 Cr |
Revenue (TTM) | : | ₹ 840.7 Cr |
Net Profit(TTM) | : | ₹ 61.9 Cr |
EPS (TTM) | : | ₹ 6.2 |
P/E (TTM) | : | 56.6 |
Industry Peers & Returns | 1W | 1M | 1Y |
GUFIC BIOSCIENCES | -3.6% | -5.5% | -17.3% |
SUN PHARMACEUTICAL INDUSTRIES | 2.2% | 2.1% | -10.7% |
DIVIS LABORATORIES | 0.3% | 6.4% | 8.7% |
CIPLA | 6.8% | 5.6% | 5.2% |
TORRENT PHARMACEUTICALS | 1.6% | -1.1% | 5.1% |
DR REDDYS LABORATORIES | 4.6% | -2.5% | -4.3% |
MANKIND PHARMA | 0% | -8.1% | -8.5% |
ZYDUS LIFESCIENCES | 2.3% | -3.6% | -1.8% |
LUPIN | 0.1% | -5.5% | -10.7% |
GUFIC BIOSCIENCES Revenues
[BOM: 509079|NSE : GUFICBIO]
Y-o-Y | 0.00 % |
5 Yr CAGR | 0.00 % |
Years | Revenues | % Change | |
---|---|---|---|
Mar2025 | ₹807 Cr | 0.00 | |
Mar2024 | ₹807 Cr | - |
GUFIC BIOSCIENCES Operating Profit
[BOM: 509079|NSE : GUFICBIO]
Y-o-Y | 0.00 % |
5 Yr CAGR | 0.00 % |
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2025 | ₹147 Cr | 0.00 | |
Mar2024 | ₹147 Cr | - |
Operating Margins | |
---|---|
Y-o-Y | 0.00 % |
5 Yr CAGR | 0.00 % |
Years | Operating Margin% | % Change | |
---|---|---|---|
Mar2025 | 18.26% | 0.00 | |
Mar2024 | 18.26% | - |
GUFIC BIOSCIENCES Profit After Tax
[BOM: 509079|NSE : GUFICBIO]
Y-o-Y | 0.00 % |
5 Yr CAGR | 0.00 % |
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2025 | ₹86 Cr | 0.00 | |
Mar2024 | ₹86 Cr | - |
PAT Margins | |
---|---|
Y-o-Y | -30.90 % |
5 Yr CAGR | -30.90 % |
Years | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2025 | 6.33 % | -30.90 | |
Mar2024 | 9.16 % | - |
GUFIC BIOSCIENCES Earnings Per Share (EPS)
[BOM: 509079|NSE : GUFICBIO]
Y-o-Y | -19.09 % |
5 Yr CAGR | -19.09 % |
Years | EPS | % Change | |
---|---|---|---|
Mar2025 | ₹6.95 | -19.09 | |
Mar2024 | ₹8.59 | - |
GUFIC BIOSCIENCES Return on Capital Employed (ROCE)
[BOM: 509079|NSE : GUFICBIO]
Y-o-Y | -13.53 % |
5 Yr CAGR | -13.53 % |
Years | ROCE | % Change | |
---|---|---|---|
Mar2025 | 13.48% | -13.53 | |
Mar2024 | 15.59% | - |
GUFIC BIOSCIENCES Share Price vs Sensex
Current Share Price | : | ₹349.3 |
Current MarketCap | : | ₹ 3,503.0 Cr |
Updated EOD on | : | Oct 21,2025 |
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GUFIC BIOSCIENCES | -3.6% |
-5.5% |
-17.3% |
SENSEX | 2.9% |
1.7% |
3.6% |
GUFIC BIOSCIENCES related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
BSE ALLCAP | 6.4% | 8.9% | 7.5% |
BSE MIDSMALLCAP | 4.7% | 9% | 8.4% |
BSE HEALTHCARE | 2.3% | 0.7% | 1.7% |
BSE SMALLCAP | 2.3% | -1.3% | -6.2% |
You may also like the below Video Courses
FAQ about GUFIC BIOSCIENCES Financials
How the annual revenues of GUFIC BIOSCIENCES have changed ?
The Revenues of GUFIC BIOSCIENCES have decreased by 0.00% YoY .
How the Earnings per Share (EPS) of GUFIC BIOSCIENCES have changed?
The Earnings Per Share (EPS) of GUFIC BIOSCIENCES has decreased by -19.09 % YoY .
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs